150
Participants
Start Date
February 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Opioid drug + CNS-acting add-on drug
Patients suffering from persistent pain (pain lasting for at least three months), already treated with an opioid medication (treatment A) and to whom the treating physician is about to prescribe a CNS-acting add-on drug such as an antiepileptic, an antidepressant, a benzodiazepine or an alpha2-agonist (treatment B: the combination treatment).
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Université Catholique de Louvain
OTHER